Abstract:Hypertension remains the leading cause of morbidity and mortality worldwide. Despite its prevalence, the development of novel antihypertensive therapies has only recently accelerated, with novel agents not yet commercialized, leaving a substantial proportion of individuals resistant to existing treatments. The intricate pathophysiology of hypertension is now understood to involve chronic low-grade inflammation, which places the immune system in the spotlight as a potential target for new therapeutics. This review explores the factors that initiate and sustain an immune response in hypertension, offering insights into potential targets for new treatments. Several factors contribute to immune activation in hypertension, including diet and damage-associated molecular pattern (DAMP) generation. Diets rich in fat or sodium can promote inflammation by inducing intestinal barrier dysfunction and triggering salt-sensitive receptors in T cells and dendritic cells. DAMPs, such as extracellular adenosine triphosphate and heat-shock protein 70, are released during episodes of increased blood pressure, contributing to immune cell activation and inflammation. Unconventional innate-like γδ T cells contribute to initiating and maintaining an immune response through their potential involvement in antigen presentation and regulating cytokine-mediated responses. Immunologic memory, sustained through the formation of effector memory T cells after exposure to hypertensive insults, likely contributes to maintaining an immune response in hypertension. When exposed to hypertensive insults, these memory cells are rapidly activated and contribute to elevated blood pressure and end-organ damage. Evidence from human hypertension, although limited, supports the relevance of distinct immune pathways in hypertension, and highlights the potential of targeted immune interventions in human hypertension.

Inflammation, Immunity, and Oxidative Stress in Hypertension-Partners in Crime?

Role of inflammation, immunity, and oxidative stress in hypertension: New insights and potential therapeutic targets

Microglia, autonomic nervous system, immunity and hypertension: Is there a link?

Inflammation and Hypertension: New Understandings and Potential Therapeutic Targets

Inflammation and hypertension: Underlying mechanisms and emerging understandings

Oxidative Stress, Antioxidants and Hypertension

Immune mechanisms in the pathophysiology of hypertension

Hypertension: Do Inflammation and Immunity Hold the Key to Solving this Epidemic?

Pathophysiology of Hypertension New paradigms in inflammatory signaling in vascular endothelial cells

Immune and inflammatory mechanisms in hypertension

Immunological insights into hypertension: unraveling triggers and potential therapeutic avenues

The bidirectional interaction between the sympathetic nervous system and immune mechanisms in the pathogenesis of hypertension

Oxidative Stress and Hypertension

Vascular Inflammation and Oxidative Stress: Major Triggers for Cardiovascular Disease

Advances in Understanding of the Role of Immune Cell Phenotypes in Hypertension and Associated Vascular Disease

Reactive oxygen species in hypertension

Toll-Like Receptors in the Pathogenesis of Essential Hypertension. A Forthcoming Immune-Driven Theory in Full Effect

The immunology of hypertension

Inflammation in Metabolic and Cardiovascular Disorders—Role of Oxidative Stress

Arterial Hypertension and Interleukins: Potential Therapeutic Target or Future Diagnostic Marker?

Recent advancements in targeting the immune system to treat hypertension